Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-03-27
2007-03-27
Stockton, Laura L. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S118000
Reexamination Certificate
active
11181098
ABSTRACT:
Methods for the treatment of psychotic or intellectual impairment disorders with compounds of formula I,wherein A, R and R1are as defined in the specification.
REFERENCES:
patent: 6110914 (2000-08-01), Phillips et al.
patent: 6706878 (2004-03-01), Phillips et al.
patent: 0311313 (1989-04-01), None
patent: WO 96/06098 (1996-02-01), None
patent: WO 97/05139 (1997-02-01), None
patent: WO 97/41125 (1997-11-01), None
patent: WO 99/03859 (1999-01-01), None
patent: PCT/SE99/02478 (2000-05-01), None
CAS ONLINE display of structures 1-87 from WO 99/03859, Phillips et al. Dec. 8, 1999.
Nordvall, G. et al., “3-(2-Benzofuranyl)quinclidin-2-ene Derivatives: Novel Muscarinic Antagonists,” J. Med. Chem., vol. 39, 1996, pp. 3269-3277, compound 9.
Loch, III James T
Mullen George B
Phillips Eifion D
AstraZeneca AB
Mitchell Kenneth F.
Stockton Laura L.
LandOfFree
Substituted amines of spirofuropyridines useful in therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted amines of spirofuropyridines useful in therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted amines of spirofuropyridines useful in therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3784417